An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma

BACKGROUND: We sought to assess the benefit-risk balance of FOLFIRINOX versus gemcitabine in patients with metastatic pancreatic adenocarcinoma. METHODS: We used generalized pairwise comparisons. This statistical method permits the simultaneous analysis of several prioritized outcome measures. The f...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Péron, Julien, Roy, Pascal, Conroy, Thierry, Desseigne, Françoise, Ychou, Marc, Gourgou-Bourgade, Sophie, Stanbury, Trevor, Roche, Laurent, Ozenne, Brice, Buyse, Marc
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5347744/
https://ncbi.nlm.nih.gov/pubmed/27765912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12761
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados